Group B Streptococcus in Pregnancy: Screening and Treatment
DOI:
https://doi.org/10.56294/hl2025592Keywords:
Group B streptococcus (GBS), pregnancy, live birth, new-born, chemoprophylaxisAbstract
Several healthy women frequently harbor the bacteria group B streptococcus (GBS) in their vaginal or rectal regions. Nevertheless, it can lead to life-threatening infections in new-born, especially in the initial couple of days after birth. The significance of identifying and treating GBS in pregnant women is discussed in this paper in preventing the bacteria from infecting unborn children. The effectiveness of recommendations was evaluated using a retrospective sample from Active Bacterial Core inspection, which tracks invasive GBS illness in various states. Data from Laboure and delivery files of births that were live and early-onset GBS cases in infants younger than 10 days old between the year 2017 and 2018 were analyzed. The results were contrasted with a used comparable methodology and examined screening procedures in the years 2012 and 2013. We looked at the birth information for 254 babies who had GBS illness and 9046 babies who didn't. During 2012-2013 and 2017-2018, testing before birth rose from 49.8% to 88.4%, and the use of antibiotics rose from 29.5% to 34.2%. Only 60% of preterm women with uncertain condition underwent chemoprophylaxis, compared to 85% of term women who tested positive for GBS. With 72.2% of cases affecting term newborns, the total early-onset GBS sickness rate: 0.3 cases per 1000 live births. 13.4% of instances among term moms included missed testing. All screening suggestions were quickly implemented. Early-onset GBS illness may not recur if preterm deliveries are managed better and culture findings are collected, processed, and reported better.
References
1. Sharpe M, Shah V, Freire-Lizama T, Cates EC, McGrath K, David I, Cowan S, Letkeman J, Stewart-Wilson E. Effectiveness of oral intake of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on Group B Streptococcus colonization during pregnancy: a midwifery-led double-blind randomized controlled pilot trial. The Journal of Maternal-Fetal & Neonatal Medicine. 2021 Jun 3;34(11):1814-21. https://doi.org/10.1080/14767058.2019.1650907
2. Seedat F, Geppert J, Stinton C, Patterson J, Freeman K, Johnson SA, Fraser H, Brown CS, Uthman OA, Tan B, Robinson ER. Universal antenatal screening for group B streptococcus may cause more harm than good. Bmj. 2019 Feb 20;364. https://doi.org/10.1136/bmj.l463
3. Haimbodi EL, Mukesi M, Moyo SR. Prevalence and molecular characterization of group B streptococcus in pregnant women from hospitals in Ohangwena and Oshikoto regions of Namibia. BMC microbiology. 2021 Dec;21:1-9. https://doi.org/10.1186/s12866-021-02283-2
4. Dhudasia MB, Flannery DD, Pfeifer MR, Puopolo KM. Updated Guidance: Prevention and management of perinatal Group B streptococcus infection. Neoreviews. 2021 Mar 1;22(3):e177-88. https://doi.org/10.1542/neo.22-3-e177
5. Furfaro LL, Chang BJ, Payne MS. Detection of group B Streptococcus during antenatal screening in Western Australia: a comparison of culture and molecular methods. Journal of Applied Microbiology. 2019 Aug 1;127(2):598-604. https://doi.org/10.1111/jam.14331
6. Bevan D, White A, Marshall J, Peckham C. Modelling the effect of the introduction of antenatal screening for group B Streptococcus (GBS) carriage in the UK. BMJ open. 2019 Mar 1;9(3):e024324. https://doi.org/10.1136/bmjopen-2018-024324
7. Rao GG, Khanna P. To screen or not to screen women for Group B Streptococcus (Streptococcus agalactiae) to prevent early onset sepsis in newborns: recent advances in the unresolved debate. Therapeutic Advances in Infectious Disease. 2020 Jul; 7:2049936120942424. https://doi.org/10.1177/2049936120942424
8. Virranniemi M, Raudaskoski T, Haapsamo M, Kauppila J, Renko M, Peltola J, Risteli L, Laatio L. The effect of screening‐to‐labor interval on the sensitivity of late‐pregnancy culture in the prediction of group B streptococcus colonization at labor: A prospective multicenter cohort study. Acta obstetricia et gynecologica Scandinavica. 2019 Apr;98(4):494-9. https://doi.org/10.1111/aogs.13522
9. Raabe VN, Shane AL. Group B streptococcus (Streptococcus agalactiae). Microbiology spectrum. 2019 Mar 22;7(2):10-128.
10. Dilrukshi GN, Kottahachchi J, Dissanayake DM, Pathiraja RP, Karunasingha J, Sampath MK, Vidanage UA, Fernando SS. Group B Streptococcus colonisation and their antimicrobial susceptibility among pregnant women attending antenatal clinics in tertiary care hospitals in the Western Province of Sri Lanka. Journal of Obstetrics and Gynaecology. 2021 Jan 2;41(1):1-6. https://doi.org/10.1080/01443615.2020.1716313
11. Jiang L, Zeng W, Wu W, Deng Y, He F, Liang W, Huang M, Huang H, Li Y, Wang X, Su H. Development and clinical evaluation of a CRISPR-based diagnostic for rapid group B Streptococcus screening. Emerging Infectious Diseases. 2021 Sep;27(9):2379. https://doi.org/10.3201/eid2709.200091
12. Le Doare K, Heath PT, Plumb J, Owen NA, Brocklehurst P, Chappell LC. Uncertainties in screening and prevention of group B Streptococcus disease. Clinical Infectious Diseases. 2019 Aug 1;69(4):720-5. https://doi.org/10.1093/cid/ciy1069
13. Lin Y, Ye J, Luo M, Hu B, Wu D, Wen J, Yang C, Li Y, Ning Y. Group B Streptococcus DNA copy numbers measured by digital PCR correlates with perinatal outcomes. Analytical Chemistry. 2019 Jul 3;91(15):9466-71. https://pubs.acs.org/doi/abs/10.1021/acs.analchem.8b05872
14. Berardi A, Spada C, Reggiani ML, Creti R, Baroni L, Capretti MG, Ciccia M, Fiorini V, Gambini L, Gargano G, Papa I. Group B Streptococcus early-onset disease and observation of well-appearing newborns. PLoS One. 2019 Mar 20;14(3):e0212784. https://doi.org/10.1371/journal.pone.0212784
15. Brigtsen AK, Jacobsen AF, Dedi L, Melby KK, Espeland CN, Fugelseth D, Whitelaw A. Group B Streptococcus colonization at delivery is associated with maternal peripartum infection. Plos one. 2022 Apr 1;17(4):e0264309. https://doi.org/10.1371/journal.pone.0264309
16. Huang J, Zheng L, Su Y, Wang F, Kong H, Chang Y, Xin H. Effects of group B streptococcus infection on vaginal micro-ecology and pregnancy outcomes of pregnant women in late pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021 Dec 1;267:274-9. https://doi.org/10.1016/j.ejogrb.2021.11.419
17. Safari D, Gultom SM, Tafroji W, Azzahidah A, Soesanti F, Khoeri MM, Prayitno A, Pimenta FC, da Gloria Carvalho M, Uiterwaal CS, Putri ND. Prevalence, serotype and antibiotic susceptibility of Group B Streptococcus isolated from pregnant women in Jakarta, Indonesia. PLoS One. 2021 May 27;16(5):e0252328. https://doi.org/10.1371/journal.pone.0252328
18. Johansen NR, Kjærbye-Thygesen A, Jønsson S, Westh H, Nilas L, Rørbye C. Prevalence and treatment of group B streptococcus colonization based on risk factors versus intrapartum culture screening. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2019 Sep 1;240:178-81. https://doi.org/10.1016/j.ejogrb.2019.06.037
19. Mejia ME, Robertson CM, Patras KA. Interspecies interactions within the host: the social network of group B Streptococcus. Infection and immunity. 2023 Apr 18;91(4):e00440-22. https://doi.org/10.1128/iai.00440-22
20. Choi SJ, Kang J, Uh Y. Recent epidemiological changes in group B streptococcus among pregnant Korean women. Annals of laboratory medicine. 2021 Jul 1;41(4):380-5. https://doi.org/10.3343/alm.2021.41.4.380.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ramaprabhu Z, Bodireddy Vamalatha, Avijit Mazumder , Deepak Minhas , Basanta Kumar Pati, Aashim Dhawan (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
